Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ganglioneuroblastoma × Temozolomide × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 37 Brain Neoplasms 16 Astrocytoma 16 Central Nervous System Neoplasms 9 Oligodendroglioma 8 Gliosarcoma 8 Melanoma 7 Glioma 7 Neoplasms 5 Recurrence 4 Neoplasm Metastasis 3 Diffuse Intrinsic Pontine Glioma 2 Choroid Plexus Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Sarcoma, Ewing 1 Sarcoma 1 Rhabdoid Tumor 1 Rare Diseases 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Neuroepithelial 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms, Bone Tissue 1 Neoplasms by Histologic Type 1 Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms 1 Lymphoma, Follicular 1

Interventions

dinutuximab 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Biopsy 2 sargramostim 1 lorlatinib 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Topotecan 1 Thiotepa 1 Temozolomide 1 Stem Cell Transplantation 1 Specimen Handling 1 Razoxane 1 Radiation 1 Platinum 1 Observation 1 Melphalan 1 Isotretinoin 1 Irinotecan 1 High-Energy Shock Waves 1 Etoposide 1 Dexrazoxane 1 Congresses as Topic 1 Colony-Stimulating Factors 1 Cisplatin 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07375563 2026-01-29

NB-NK-2026

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡